RECENT NEWS

The British In Vitro Diagnostics Association (BIVDA) has launched the latest in its series of strategic papers, The Digital Revolution.

Sphere Fluidics and ClexBio have announced the launch of the biocompatible CYTRIX Microfluidic Hydrogel Kit, which combines ClexBio’s novel CYTRIX Hydrogel with Sphere Fluidics’ specially designed Pico-Gen double aqueous biochip.

Proscia has introduced the next generation of its flagship Concentriq platform to help the world’s largest laboratory networks keep pace with the growing need for diagnostic services in the post-COVID era.

Beckman Coulter has announced the launch of an anti-Müllerian hormone (AMH) test that uses a validated cut-off to aid in the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilisation (IVF).

CytoSMART Technologies has announced the launch of two new fluorescence live-cell imaging systems – the Lux3 FL Duo Kit and the Multi Lux3 FL.

Binding Site has announced that the iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) study has reached an important milestone, with the publication of a paper outlining the design and recruitment of this population-based screening study

The British In Vitro Diagnostics Association (BIVDA) has responded to the communique published by the attendees at the G7 meeting in Cornwall, pledging to do more to tackle the problem of antimicrobial resistance (AMR).

Bio-Rad Laboratories has introduced StarBright Violet 570, 670 and 710 dyes, which offer improved brightness and precise excitation and emission spectra, making them suitable for use in multicolour flow cytometry panels.

An international team of scientists has identified key factors underpinning the development of bowel or colorectal cancer in patients with a genetic predisposition to the disease.

Medical Analytics, a pioneer in artificial intelligence (AI)-powered cancer diagnostics, has gained CE-marking for the Galen Breast solution for use in supporting pathologists in detection of various types of breast cancer.

Indica Labs and Ibex Medical Analytics have announced an agreement to integrate the Galen AI-based cancer diagnostics platform into the HALO AP digital pathology workflow platform.

The British In Vitro Diagnostics Association (BIVDA) has written to the President of COP26, Alok Sharma MP, to offer the support of the industry for the forthcoming COP26 summit in Glasgow.

Viruses are endlessly fascinating. That is why, despite branching out into other areas of microbiology during her career, Dr Sarah Pitt is always pulled back to the virology specialty.

HORIBA UK, Medical offers a blood cell morphology-focused newsletter that draws on HORIBA Medical’s haematology expertise. The Quality Slide Program (QSP) newsletter includes morphology case studies, top morphology tips, slide reviews and quizzes.

Menarini Diagnostics has expanded its HistoDream range of equipment with the new semi-automated HistoDream M microtome, which maximises operator safety during use, with features such as a finger guard and a hand lock in every position.

Low loading height, wide door swing, advanced programming for simple to complex sterilising tasks, effective use of power and water are just a few of the user benefits from the Priorclave QCS range of research-grade laboratory autoclaves.

Researchers at the Ludwig Maximilian University of Munich are focused on the rapid translation of drugs for use in childhood brain tumours, and the INTEGRA family of products has been a part of the laboratory since its inception.

A recent study published by the research group of Professor Francesco Di Mario at Parma University, Italy, found a strong relationship between low levels of plasma gastrin-17 (G-17) and gastro-oesophageal reflux disease (GORD).

Preventative maintenance of pipettes is critical and essential. They require regular servicing, cleaning and calibration to ensure they operate within specification and deliver reproducible data.

Flow Eighteen38 and FairJourney Biologics (FJB) have announced an agreement with the Hubrecht Institute to harness the potential of FJB’s proprietary llama naïve libraries to develop antibodies to be used as research tools for the Hans Clevers group.